133 related articles for article (PubMed ID: 20093484)
1. ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
Koo BH; Coe DM; Dixon LJ; Somerville RP; Nelson CM; Wang LW; Young ME; Lindner DJ; Apte SS
Am J Pathol; 2010 Mar; 176(3):1494-504. PubMed ID: 20093484
[TBL] [Abstract][Full Text] [Related]
2. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.
Lee YJ; Koch M; Karl D; Torres-Collado AX; Fernando NT; Rothrock C; Kuruppu D; Ryeom S; Iruela-Arispe ML; Yoon SS
Cancer Res; 2010 Feb; 70(3):948-56. PubMed ID: 20103648
[TBL] [Abstract][Full Text] [Related]
3. Endothelial FAK is required for tumour angiogenesis.
Tavora B; Batista S; Reynolds LE; Jadeja S; Robinson S; Kostourou V; Hart I; Fruttiger M; Parsons M; Hodivala-Dilke KM
EMBO Mol Med; 2010 Dec; 2(12):516-28. PubMed ID: 21154724
[TBL] [Abstract][Full Text] [Related]
4. Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies.
Lu Z; Ortiz A; Verginadis II; Peck AR; Zahedi F; Cho C; Yu P; DeRita RM; Zhang H; Kubanoff R; Sun Y; Yaspan AT; Krespan E; Beiting DP; Radaelli E; Ryeom SW; Diehl JA; Rui H; Koumenis C; Fuchs SY
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998600
[TBL] [Abstract][Full Text] [Related]
5. Solutions of a linearized mathematical model for capillary formation in tumor angiogenesis: an initial data perturbation approximation.
Pamuk S
Comput Math Methods Med; 2013; 2013():789402. PubMed ID: 24027602
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
7. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.
Lo PH; Lung HL; Cheung AK; Apte SS; Chan KW; Kwong FM; Ko JM; Cheng Y; Law S; Srivastava G; Zabarovsky ER; Tsao SW; Tang JC; Stanbridge EJ; Lung ML
Cancer Res; 2010 Jul; 70(13):5567-76. PubMed ID: 20551050
[TBL] [Abstract][Full Text] [Related]
8. A new Adamts9 conditional mouse allele identifies its non-redundant role in interdigital web regression.
Dubail J; Aramaki-Hattori N; Bader HL; Nelson CM; Katebi N; Matuska B; Olsen BR; Apte SS
Genesis; 2014 Jul; 52(7):702-12. PubMed ID: 24753090
[TBL] [Abstract][Full Text] [Related]
9. Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.
Kern CB; Wessels A; McGarity J; Dixon LJ; Alston E; Argraves WS; Geeting D; Nelson CM; Menick DR; Apte SS
Matrix Biol; 2010 May; 29(4):304-16. PubMed ID: 20096780
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study in Spanish identifies ADAM metallopeptidase with thrombospondin type 1 motif, 9 (ADAMTS9), as a novel asthma susceptibility gene.
Barreto-Luis A; Pino-Yanes M; Corrales A; Campo P; Callero A; Acosta-Herrera M; Cumplido J; Ma SF; Martinez-Tadeo J; Villar J; Garcia JG; Carrillo T; Carracedo Á; Blanca M; Flores C
J Allergy Clin Immunol; 2016 Mar; 137(3):964-6. PubMed ID: 26620591
[No Abstract] [Full Text] [Related]
11. Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics.
Dubail J; Apte SS
Matrix Biol; 2015; 44-46():24-37. PubMed ID: 25770910
[TBL] [Abstract][Full Text] [Related]
12. A disintegrin-like and metalloproteinase domain with thrombospondin type 1 motif 9 (ADAMTS9) regulates fibronectin fibrillogenesis and turnover.
Wang LW; Nandadasa S; Annis DS; Dubail J; Mosher DF; Willard BB; Apte SS
J Biol Chem; 2019 Jun; 294(25):9924-9936. PubMed ID: 31085586
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS9 Regulates Skeletal Muscle Insulin Sensitivity Through Extracellular Matrix Alterations.
Graae AS; Grarup N; Ribel-Madsen R; Lystbæk SH; Boesgaard T; Staiger H; Fritsche A; Wellner N; Sulek K; Kjolby M; Backe MB; Chubanava S; Prats C; Serup AK; Birk JB; Dubail J; Gillberg L; Vienberg SG; Nykjær A; Kiens B; Wojtaszewski JFP; Larsen S; Apte SS; Häring HU; Vaag A; Zethelius B; Pedersen O; Treebak JT; Hansen T; Holst B
Diabetes; 2019 Mar; 68(3):502-514. PubMed ID: 30626608
[TBL] [Abstract][Full Text] [Related]
14. Mutations of ADAMTS9 Cause Nephronophthisis-Related Ciliopathy.
Choi YJ; Halbritter J; Braun DA; Schueler M; Schapiro D; Rim JH; Nandadasa S; Choi WI; Widmeier E; Shril S; Körber F; Sethi SK; Lifton RP; Beck BB; Apte SS; Gee HY; Hildebrandt F
Am J Hum Genet; 2019 Jan; 104(1):45-54. PubMed ID: 30609407
[TBL] [Abstract][Full Text] [Related]
15. Expression Profiling of
Suri F; Biginaloo A; Ghadimi M; Banadaki HD; Paylakhi SH; Kanavi MR
Iran J Public Health; 2023 Dec; 52(12):2630-2642. PubMed ID: 38435780
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS Gene-Derived circRNA Molecules in Non-Small-Cell Lung Cancer: Expression Profiling, Clinical Correlations and Survival Analysis.
Pietrzak J; Świechowski R; Wosiak A; Wcisło S; Balcerczak E
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339175
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies.
Reichart D; Lindberg EL; Maatz H; Miranda AMA; Viveiros A; Shvetsov N; Gärtner A; Nadelmann ER; Lee M; Kanemaru K; Ruiz-Orera J; Strohmenger V; DeLaughter DM; Patone G; Zhang H; Woehler A; Lippert C; Kim Y; Adami E; Gorham JM; Barnett SN; Brown K; Buchan RJ; Chowdhury RA; Constantinou C; Cranley J; Felkin LE; Fox H; Ghauri A; Gummert J; Kanda M; Li R; Mach L; McDonough B; Samari S; Shahriaran F; Yapp C; Stanasiuk C; Theotokis PI; Theis FJ; van den Bogaerdt A; Wakimoto H; Ware JS; Worth CL; Barton PJR; Lee YA; Teichmann SA; Milting H; Noseda M; Oudit GY; Heinig M; Seidman JG; Hubner N; Seidman CE
Science; 2022 Aug; 377(6606):eabo1984. PubMed ID: 35926050
[TBL] [Abstract][Full Text] [Related]
18. The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis.
Li T; Peng J; Li Q; Shu Y; Zhu P; Hao L
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883515
[TBL] [Abstract][Full Text] [Related]
19. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
Yang H; Khalil RA
Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
